Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back
Industry Event: Innovation Theater

203: SAPHNELO® (anifrolumab-fnia): A First-In-Class IFN-1 Signaling Inhibitor, Now With 4-Year Data From a Long-Term Safety and Tolerability Study

Sunday, November 12, 2023
12:30 PM – 1:15 PM PT
Location: Theater A

    Developed and offered by AstraZeneca

    Non-CME